Naveen S. Basappa

2.3k citations
97 papers · 1.5k · 3 hit papers · h-index 21

Impact in

    • Renal cell carcinoma treatment
    • Prostate Cancer Treatment and Research
    • Lung Cancer Treatments and Mutations
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research

Papers in

Naveen S. Basappa

88 papers receiving 1.5k citations

Naveen S. Basappa's Hit Papers

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study 2024 · 129 citations
1290+1+2Years since publication4080120

Peers

Naveen S. Basappa
Comparison fields: 5 of 77
  • Pulmonary and Respiratory Medicine 935
  • Oncology 433
  • Cancer Research 179
  • Molecular Biology 289
  • Surgery 113
Replace Yasuo Kakugawa with:
Yasuo Kakugawa Japan
Akihiro Nishiyama Japan
Gabriel Tinoco United States
Lieming Ding China
Carlo Cattrini Italy
Júlio Oliveira Portugal
Alessandro Del Conte Italy
Ettore D’Argento Italy
Lakshminarayanan Nandagopal United States
Deepak Kilari United States
Naveen S. Basappa relative to Yasuo Kakugawa Japan Yasuo Kakugawa's profile →
Citations per field
00.5×5×10×15×20×22.6×
Yasuo Kakugawa · 1×
Citations per year

Countries citing papers authored by Naveen S. Basappa

Since Specialization
Citations

This map shows the geographic impact of Naveen S. Basappa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naveen S. Basappa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naveen S. Basappa more than expected).

Fields of papers citing papers by Naveen S. Basappa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naveen S. Basappa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naveen S. Basappa. The network helps show where Naveen S. Basappa may publish in the future.

Co-authors

The 25 scholars most cited alongside Naveen S. Basappa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Naveen S. Basappa Line = papers co-authored together Naveen S. Basappa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
Hit paper breakdown →
2024129
2
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study
Hit paper breakdown →
2023121
3
Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study
Hit paper breakdown →
202497
4 201484
5 201863
6 201952
7 202052
8 201946
9 202345
10 202342
11 202140
12 201735
13 201731
14 202131
15 201929
16 202227
17 201925
18 201925
19 202025
20 201024

About Naveen S. Basappa

Naveen S. Basappa is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Cancer Research and Economics and Econometrics, having authored 97 papers that have together received 1.5k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (60 papers), Prostate Cancer Treatment and Research (13 papers), Cancer Immunotherapy and Biomarkers (10 papers), Renal and related cancers (10 papers), Bladder and Urothelial Cancer Treatments (10 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (5 papers) and Economic and Financial Impacts of Cancer (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (935 citations), Oncology (433 citations), Cancer Research (179 citations), Molecular Biology (289 citations) and Surgery (113 citations). Naveen S. Basappa has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Lori Anne Wood, Daniel Y.C. Heng, Christian Kollmannsberger, Quincy Siu-Chung Chu, Michael Smylie, Anil Kapoor, Denis Soulières, Georg Arnold Bjarnason, Toni K. Choueiri and John Connor Wells. Their work appears in journals such as Annals of Oncology, The Journal of Urology, European Urology, Clinical Genitourinary Cancer and European Urology Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact